BNGO Bionano Genomics, Inc.

NASDAQ
$0.95

Bionano Genomics, Inc. (BNGO) is expected to report earnings on February 9, 2027, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of -18.6% since its last earnings release on November 10, 2026.

Bionano Genomics Missed Consensus Estimates, Reaffirms
Tuesday, November 10, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 9
Tuesday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.03

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Bionano Genomics, Inc.

Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.